Bcl-2 Protein Expression in Breast Carcinomas
Author Information
Author(s): C Charpin, S Garcia, C Bouvier, B Devictor, L Andrac, M-N Lavaut, C Allasia
Primary Institution: Department of Pathology, Faculté de Médecine Timone and Department of Pathology, Hôpital Nord Marseilles, France
Hypothesis
The study investigates the expression of the bcl-2 gene in human breast carcinomas and its correlation with prognostic indicators.
Conclusion
Bcl-2 protein expression is inversely related to tumor grade and associated with hormone receptor status in breast carcinomas.
Supporting Evidence
- Bcl-2 expression was detected in 78% of the breast carcinomas studied.
- An inverse relationship was observed between Bcl-2 expression and tumor grades.
- Bcl-2 expression was significantly associated with ER-positive tumors.
- Bcl-2 protein expression may be involved in response to endocrine therapy.
Takeaway
This study looked at a protein called Bcl-2 in breast cancer samples to see how it relates to tumor characteristics. They found that lower grades of tumors had more Bcl-2, which might help doctors understand how to treat patients better.
Methodology
The study used immunohistochemical analysis on frozen sections of breast carcinoma samples to evaluate Bcl-2 protein expression.
Potential Biases
Potential biases may arise from the subjective nature of semiquantitative analysis in previous studies.
Limitations
The study's results may not be directly comparable to previous studies due to variations in methods of detection.
Participant Demographics
Mean age of participants was 56.7 years, with a range from 32 to 83 years.
Statistical Information
P-Value
P < 0.0001
Statistical Significance
p<0.0001
Want to read the original?
Access the complete publication on the publisher's website